Copyright Reports & Markets. All rights reserved.

Global and China Cancer Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Platform-based
    • 1.2.3 Instrument-based
  • 1.3 Market by Application
    • 1.3.1 Global Cancer Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Breast Cancer
    • 1.3.3 Lung Cancer
    • 1.3.4 Colorectal Cancer
    • 1.3.5 Melanoma
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Cancer Diagnostics Growth Trends by Regions
    • 2.2.1 Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Diagnostics Players by Market Size
    • 3.1.1 Global Top Cancer Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
  • 3.4 Global Cancer Diagnostics Market Concentration Ratio
    • 3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2019
  • 3.5 Key Players Cancer Diagnostics Area Served
  • 3.6 Key Players Cancer Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Cancer Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Cancer Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Cancer Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Cancer Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Diagnostics Market Size (2015-2026)
  • 6.2 North America Cancer Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Cancer Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Cancer Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Cancer Diagnostics Market Size (2015-2026)
  • 7.2 Europe Cancer Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Cancer Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Cancer Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Cancer Diagnostics Market Size (2015-2026)
  • 8.2 China Cancer Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Cancer Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Cancer Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Cancer Diagnostics Market Size (2015-2026)
  • 9.2 Japan Cancer Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Cancer Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Cancer Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Cancer Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Cancer Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Cancer Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Cancer Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Becton, Dickinson and Company
    • 11.1.1 Becton, Dickinson and Company Company Details
    • 11.1.2 Becton, Dickinson and Company Business Overview
    • 11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
    • 11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2015-2020))
    • 11.1.5 Becton, Dickinson and Company Recent Development
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Company Details
    • 11.2.2 GE Healthcare Business Overview
    • 11.2.3 GE Healthcare Cancer Diagnostics Introduction
    • 11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.2.5 GE Healthcare Recent Development
  • 11.3 Abbott
    • 11.3.1 Abbott Company Details
    • 11.3.2 Abbott Business Overview
    • 11.3.3 Abbott Cancer Diagnostics Introduction
    • 11.3.4 Abbott Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.3.5 Abbott Recent Development
  • 11.4 Roche
    • 11.4.1 Roche Company Details
    • 11.4.2 Roche Business Overview
    • 11.4.3 Roche Cancer Diagnostics Introduction
    • 11.4.4 Roche Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.4.5 Roche Recent Development
  • 11.5 Thermo Fisher Scientific
    • 11.5.1 Thermo Fisher Scientific Company Details
    • 11.5.2 Thermo Fisher Scientific Business Overview
    • 11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
    • 11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.5.5 Thermo Fisher Scientific Recent Development
  • 11.6 Agilent Technologies
    • 11.6.1 Agilent Technologies Company Details
    • 11.6.2 Agilent Technologies Business Overview
    • 11.6.3 Agilent Technologies Cancer Diagnostics Introduction
    • 11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.6.5 Agilent Technologies Recent Development
  • 11.7 Illumina
    • 11.7.1 Illumina Company Details
    • 11.7.2 Illumina Business Overview
    • 11.7.3 Illumina Cancer Diagnostics Introduction
    • 11.7.4 Illumina Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.7.5 Illumina Recent Development
  • 11.8 Siemens Healthcare
    • 11.8.1 Siemens Healthcare Company Details
    • 11.8.2 Siemens Healthcare Business Overview
    • 11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
    • 11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.8.5 Siemens Healthcare Recent Development
  • 11.9 C.R. Bard
    • 11.9.1 C.R. Bard Company Details
    • 11.9.2 C.R. Bard Business Overview
    • 11.9.3 C.R. Bard Cancer Diagnostics Introduction
    • 11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2015-2020)
    • 11.9.5 C.R. Bard Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Cancer Diagnostics Scope and Market Size
    Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Platform-based
    Instrument-based

    Market segment by Application, split into
    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Melanoma
    Others

    Based on regional and country-level analysis, the Cancer Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Becton, Dickinson and Company
    GE Healthcare
    Abbott
    Roche
    Thermo Fisher Scientific
    Agilent Technologies
    Illumina
    Siemens Healthcare
    C.R. Bard

    Buy now